Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy C Thompson

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Science Translational Medicine|May 4, 2018
ER stress in prostate cancer: A therapeutically exploitable vulnerability?Christopher Logothetis, Ana Aparicio, Timothy C Thompson
Cancer Biology & Therapy|November 20, 2009
Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cellsSalahaldin A Tahir, Sanghee Park, Timothy C Thompson
Asian Journal of Urology|March 8, 2018
Novel anti-androgen receptor signaling agents: Understanding the mechanisms of resistanceStyliani Karanika, Theodoros Karantanos, Jianhua Yin, et al.
Expert Review of Anticancer Therapy|July 13, 2002
Gene therapy for prostate cancerYehoshua Gdor, Terry L Timme, Brian J Miles, et al.
Molecular and Cellular Biology|December 4, 2003
Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2ALikun Li, Cheng Hui Ren, Salahaldin A Tahir, et al.
Genomics|May 23, 2006
Identification and characterization of RTVP1/GLIPR1-like genes, a novel p53 target gene clusterChengzhen Ren, Cheng-Hui Ren, Likun Li, et al.
Cancer|February 16, 2005
Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progressionGuang Yang, Terry L Timme, Anna Frolov, et al.
Cancer Biology & Therapy|December 17, 2005
CDC4 gene expression as potential biomarker for targeted therapy in prostate cancerMoon S Koh, Michael Ittmann, Dov Kadmon, et al.
European Urology|October 13, 2014
Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular levelTheodoros Karantanos, Christopher P Evans, Bertrand Tombal, et al.
Cancer Research|March 18, 2004
Reduced infiltration of class A scavenger receptor positive antigen-presenting cells is associated with prostate cancer progressionGuang Yang, Josephine Addai, Wei-hua Tian, et al.
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Science Translational Medicine|May 4, 2018
ER stress in prostate cancer: A therapeutically exploitable vulnerability?Christopher Logothetis, Ana Aparicio, Timothy C Thompson
Cancer Biology & Therapy|November 20, 2009
Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cellsSalahaldin A Tahir, Sanghee Park, Timothy C Thompson
Asian Journal of Urology|March 8, 2018
Novel anti-androgen receptor signaling agents: Understanding the mechanisms of resistanceStyliani Karanika, Theodoros Karantanos, Jianhua Yin, et al.
Expert Review of Anticancer Therapy|July 13, 2002
Gene therapy for prostate cancerYehoshua Gdor, Terry L Timme, Brian J Miles, et al.
Molecular and Cellular Biology|December 4, 2003
Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2ALikun Li, Cheng Hui Ren, Salahaldin A Tahir, et al.
Genomics|May 23, 2006
Identification and characterization of RTVP1/GLIPR1-like genes, a novel p53 target gene clusterChengzhen Ren, Cheng-Hui Ren, Likun Li, et al.
Cancer|February 16, 2005
Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progressionGuang Yang, Terry L Timme, Anna Frolov, et al.
Cancer Biology & Therapy|December 17, 2005
CDC4 gene expression as potential biomarker for targeted therapy in prostate cancerMoon S Koh, Michael Ittmann, Dov Kadmon, et al.
European Urology|October 13, 2014
Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular levelTheodoros Karantanos, Christopher P Evans, Bertrand Tombal, et al.
Cancer Research|March 18, 2004
Reduced infiltration of class A scavenger receptor positive antigen-presenting cells is associated with prostate cancer progressionGuang Yang, Josephine Addai, Wei-hua Tian, et al.
Pageof 12